semaglutide food aversion FDA Approves Oral Semaglutide: First GLP-1 Weight Loss Pill What Not to Eat on

Plant Pathol 14:9296

These outcomes were assessed using an intention-to-treat approach, regardless of whether participants stopped treatment early or began other weight-loss therapies

A1C & T2D Control: Tirzepatide -2.3% vs -1.8% For type 2 diabetes management, tirzepatide met superiority over semaglutide across all doses in the SURPASS-2 trial

We hope this approval supports increasing access to obesity care in the UK. The pills, which contain semaglutide, are now approved for adults who are obese (BMI of 30 or above) or overweight (BMI of 27-30) and have at least one weight-related health condition

Consider Hormone Replacement Therapy (HRT) NICE Menopause Guidelines recommend HRT for vasomotor symptoms

Rhea EM, et al